National Institute of Biomedical Imaging and Bioengineering Notice of Meeting, 40780 [2017-18120]
Download as PDF
<![CDATA[
40780
Federal Register / Vol. 82, No. 165 / Monday, August 28, 2017 / Notices
Biomedical Imaging and Bioengineering
Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel, NIBIB P41 Review
(2018/01).
Date: September 17–19, 2017.
Time: 5:00 p.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard Los Angeles LA Live, 901
West Olympic Boulevard, Los Angeles, CA
90015.
Contact Person: Ruixia Zhou, Ph.D.,
Scientific Review Officer, 6707 Democracy
Boulevard, Democracy Two Building, Suite
957, Bethesda, MD 20892, (301) 496–4773,
zhour@mail.nih.gov.
Dated: August 22, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–18122 Filed 8–25–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
asabaliauskas on DSKBBXCHB2PROD with NOTICES
National Institute of Biomedical
Imaging and Bioengineering Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council for Biomedical Imaging and
Bioengineering.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
VerDate Sep<11>2014
18:45 Aug 25, 2017
Jkt 241001
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Biomedical Imaging and
Bioengineering NACBIB Council Meeting,
September, 2017.
Date: September 12, 2017.
Open: 9:00 a.m. to 12:40 p.m.
Agenda: Report from the Institute Director,
other Institute Staff and scientific
presentation.
Place: The William F. Bolger Center,
Franklin Building, Classroom 4, 9600
Newbridge Drive, Potomac, MD 20854.
Closed: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: The William F. Bolger Center,
Franklin Building, Classroom 4, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: David T. George, Ph.D.,
Acting Associate Director, Office of Research
Administration, National Institute of
Biomedical Imaging and Bioengineering,
6707 Democracy Boulevard, Room 920,
Bethesda, MD 20892.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nibib1.nih.gov/about/NACBIB/
NACBIB.htm, where an agenda and any
additional information for the meeting
will be posted when available.
Dated: August 22, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–18120 Filed 8–25–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of an
Interagency Pain Research Coordinating
Committee (IPRCC) meeting.
The meeting will feature invited
speakers and discussions of committee
business items including updates on the
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
Federal Pain Research Strategy and new
pain initiatives.
The meeting will be open to the
public and accessible by live webcast
and conference call.
Name of Committee: Interagency Pain
Research Coordinating Committee.
Type of meeting: Open Meeting.
Date: October 23, 2017.
Time: 8:30 a.m. to 4:30 p.m. *Eastern
Time*—Approximate end time.
Agenda: The meeting will feature invited
speakers and discussions of Committee
business items including updates on the
Federal Pain Research Strategy and new pain
initiatives.
Place: National Institutes of Health,
Building 31C, 6th Floor, Room 6, 31 Center
Drive, Bethesda, MD 20892.
Cost: The meeting is free and open to the
public.
Webcast Live: https://videocast.nih.gov/.
Deadlines: Notification of intent to present
oral comments: Monday, October 17, 2017,
by 5:00 p.m. ET. Submission of written/
electronic statement for oral comments:
Monday, October 17, 2017, by 5:00 p.m. ET.
Submission of written comments: Monday,
October 17, 2017, by 5:00 p.m. ET.
Access: Medical Center Metro (Red Line).
Visitor Information: https://www.nih.gov/
about/visitor/index.htm.
Contact Person: Linda L. Porter, Ph.D.,
Pain Policy Advisor, Office of Pain Policy,
Officer of the Director, National Institute of
Neurological Disorders and Stroke, NIH, 31
Center Drive, Room 8A31, Bethesda, MD
20892, Phone: (301) 451–4460, Email:
Linda.Porter@nih.gov.
Please Note: Any member of the public
interested in presenting oral comments to the
Committee must notify the Contact Person
listed on this notice by 5:00 p.m. ET on
Monday, October 17, 2017, with their request
to present oral comments at the meeting.
Interested individuals and representatives of
organizations must submit a written/
electronic copy of the oral statement/
comments including a brief description of the
organization represented by 5:00 p.m. ET on
Monday, October 17, 2017.
Statements submitted will become a part of
the public record. Only one representative of
an organization will be allowed to present
oral comments on behalf of that organization,
and presentations will be limited to three to
five minutes per speaker, depending on
number of speakers to be accommodated
within the allotted time. Speakers will be
assigned a time to speak in the order of the
date and time when their request to speak is
received, along with the required submission
of the written/electronic statement by the
specified deadline. If special
accommodations are needed, please email
the Contact Person listed above.
In addition, any interested person may
submit written comments to the IPRCC prior
to the meeting by sending the comments to
the Contact Person listed on this notice by
5:00 p.m. ET, Monday, October 17, 2017. The
comments should include the name and,
when applicable, the business or professional
affiliation of the interested person. All
written comments received by the deadlines
E:\FR\FM\28AUN1.SGM
28AUN1
]]>Agencies
[Federal Register Volume 82, Number 165 (Monday, August 28, 2017)]
[Notices]
[Page 40780]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-18120]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering
Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Council for Biomedical Imaging and Bioengineering.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council for Biomedical
Imaging and Bioengineering NACBIB Council Meeting, September, 2017.
Date: September 12, 2017.
Open: 9:00 a.m. to 12:40 p.m.
Agenda: Report from the Institute Director, other Institute
Staff and scientific presentation.
Place: The William F. Bolger Center, Franklin Building,
Classroom 4, 9600 Newbridge Drive, Potomac, MD 20854.
Closed: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: The William F. Bolger Center, Franklin Building,
Classroom 4, 9600 Newbridge Drive, Potomac, MD 20854.
Contact Person: David T. George, Ph.D., Acting Associate
Director, Office of Research Administration, National Institute of
Biomedical Imaging and Bioengineering, 6707 Democracy Boulevard,
Room 920, Bethesda, MD 20892.
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
Information is also available on the Institute's/Center's home
page: https://www.nibib1.nih.gov/about/NACBIB/NACBIB.htm, where an
agenda and any additional information for the meeting will be posted
when available.
Dated: August 22, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-18120 Filed 8-25-17; 8:45 am]
BILLING CODE 4140-01-P
